Medicine, Infectious Diseases Division

Grants

Grants per year 1997 2014 2015 2018 2020 2027

• 1 Not started
• 149 Active
• 409 Finished

Grants per year

Search results

• Finished

  Prot# GS-US-236-0115: A Phase 3b Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI/r) plus Emtricitabine/Tenofovir Fixed-Dose Combination (FTC/TDF) to the Elvitegravir/Cobicistat/ Emt

  Achenbach, C. J., Palella Jr, F. J. & Taiwo, B. O.

  Gilead Sciences, Inc.

  1/16/12 → 1/16/15

  Project: Research project

• Prot#A4001095: A Multicenter, Randomized, Double-Blind, Comparative Trial of Maraviroc + Darunavir/Ritonavir Versus Emtricitabine /Tenofovir + Darunavir/Ritonavir for the Treatment of Antiretroviral-Naive HIV-Infected Patietns with CCR5-Tropic HIV-1

  Taiwo, B. O.

  Parexel, ViiV Healthcare

  1/9/12 → 1/9/15

  Project: Research project

• AIDS Clinical Trials Group ("ACTG") - Agreement BRS-ACURE-S-12-002376

  Taiwo, B. O.

  Social & Scientific Systems, Inc.

  1/1/12 → 5/31/14

  Project: Research project

• Neurological AIDS Research Consortium

  Taiwo, B. O.

  Washington University St. Louis, National Institute of Neurological Disorders and Stroke

  12/1/11 → 9/30/12

  Project: Research project

• HIV Outpatient Study

  Palella Jr, F. J.

  Cerner Corporation, Centers for Disease Control and Prevention

  9/30/11 → 9/29/15

  Project: Research project

• Achieving Consensus on High Risk Donors to Improve Access to Organ Transplantation

  Ison, M. G.

  Agency for Healthcare Research and Quality

  9/30/11 → 9/29/12

  Project: Research project

  • Tissue Donors 100%
  • Organ Transplantation 84%
  • Living Donors 34%
  • Congresses 22%
  • Informed Consent 22%

• A Compartmental Analysis of HIV Reservoirs and Immune Reconstitution

  Wolinsky, S. M. & Kim, E.

  University of Minnesota, National Institute of Allergy and Infectious Diseases

  9/1/11 → 8/31/12

  Project: Research project

• Aging and Fracture Risk Among HIV-infected and HIV-uninfected Men

  Palella Jr, F. J.

  Johns Hopkins University, National Institute of Allergy and Infectious Diseases

  9/1/11 → 8/31/17

  Project: Research project

• AIDS Clinical Trials Group (ACTG) Protocol A5280 (Task ORder VRS-ACRUE-S-12-002230)

  Murphy, R. L.

  Social & Scientific Systems, Inc.

  6/1/11 → 5/31/13

  Project: Research project

• Co-Chair of Women’s Health Internetwork Scientific Committee (ACTG)

  Cohn, S. E.

  Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases

  6/1/11 → 5/31/12

  Project: Research project

• Aids Clinical Trials Group ("ACTG") Protocol A5272 (Task Order VRS-ACRUE-S-1-000052-002066

  Murphy, R. L.

  Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases

  6/1/11 → 5/31/12

  Project: Research project

• Chair of Data Management Committee (ACTG)

  Murphy, R. L.

  Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases

  6/1/11 → 5/31/12

  Project: Research project

• AIDS Clinical Trials Group ("ACTG") Protocol A5280 (Task Order VRS-ACRUE-S-12-000052-002284)

  Murphy, R. L.

  Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases

  6/1/11 → 5/31/12

  Project: Research project

• The International Workshop on HIV Dynamics and Evolution

  Wolinsky, S. M.

  National Institute of Allergy and Infectious Diseases

  3/15/11 → 2/28/14

  Project: Research project

• Prot#GS-US-264-0106: A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fuma

  Palella Jr, F. J.

  Gilead Sciences, Inc.

  3/15/11 → 3/15/14

  Project: Research project

• Prot#ING111762: A Phase III Randomized, Double-Blind Study of the Safety and Efficacy of GSK1349572 50 mg Once Daily Versus Raltegravir 400 mg Twice Daily, Both Administered with an Investigator Selected Background Regimen Over 48 Weeks in HIV-1 Infected,

  Taiwo, B. O.

  GlaxoSmithKline plc, ViiV Healthcare

  2/1/11 → 2/1/14

  Project: Research project

• Comparison of T-Spot.TB Quantiferon-TB Gold Testing to detect Turberculosis in Immunocompromised Patients

  Ison, M. G.

  ViraCor, L.L.C.

  1/15/11 → 1/15/13

  Project: Research project

• IRC 002

  Ison, M. G.

  Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases

  1/1/11 → 3/31/15

  Project: Research project

• IRC 003

  Ison, M. G.

  Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases

  1/1/11 → 3/31/13

  Project: Research project

• IRC004

  Ison, M. G.

  Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases

  1/1/11 → 3/31/15

  Project: Research project

• Randomized Double-Blind Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Compination Antivirals (Amantadine, Ribavirin, Oseltamivir) versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications: Task Order #006: A

  Ison, M. G.

  Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases

  1/1/11 → 3/31/15

  Project: Research project

• Pediatric HIV/AIDS Cohort Study (PHACS): Newborn Evaluation for Effects of Maternal Tenofovir Use During Pregnancy

  Sutton, S. H.

  Ann & Robert H. Lurie Children's Hospital of Chicago, National Institute of Child Health and Human Development

  11/1/10 → 7/31/13

  Project: Research project

• NAI114373: A Phase III International, Randomized, Double-blind, Double-dummy Study to Evaluate the Efficacy and Safety of 300 mg or 600 mg of Intravenous Zanamivir Twice Daily Compared to 75 mg of Oral Oseltamivir Twice Daily in the Treatment of Hospitali

  Ison, M. G.

  GlaxoSmithKline plc

  10/21/10 → 10/31/15

  Project: Research project

• MicroRNAs and Age-Related Immune Dysfunction in HIV Infection

  Wolinsky, S. M.

  Dana-Farber Cancer Institute, National Institute on Aging

  9/30/10 → 8/31/12

  Project: Research project

• Cardiovascular and HIV/AIDS Effects on Brain Structure/Function and Cognition

  Phair, J. P. & Ragin, A.

  University of Pittsburgh, National Institute on Aging

  9/30/10 → 5/31/15

  Project: Research project